COMPANY

Virtus Therapeutics Corporation

Location: Groton, CT · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 2R44NS127740-03A1, competing renewal, notice Sep 17, 2026). NIH RePORTER 2R44NS127740-03A1 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 2R44NS127740-03A1
  Organization: VIRTUS THERAPEUTICS CORPORATION; City/State: Groton, CT; Project number: 2R44NS127740-03A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 999841; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: PanK Activators for the Treatment of Pantothenate Kinase-Associated Neurodegeneration; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — SBIR: $999,841 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NINDS. Source: government award database. source ↗

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $999,841 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NINDS. Source: government award database. source ↗